Kazuhide Nakamura

1.3k total citations
27 papers, 1.0k citations indexed

About

Kazuhide Nakamura is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Kazuhide Nakamura has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 9 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Kazuhide Nakamura's work include Angiogenesis and VEGF in Cancer (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Kazuhide Nakamura is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Kazuhide Nakamura collaborates with scholars based in Japan, United States and United Kingdom. Kazuhide Nakamura's co-authors include Masabumi Shibuya, Kazuo Kubo, Toshiyuki Isoe, Eri Taguchi, Yoichiro Iwakura, Shinobu Iwai, Sachie Hiratsuka, Mai Yamauchi, Masato Murakami and Kazumi Takahashi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Kazuhide Nakamura

27 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazuhide Nakamura Japan	18	601	249	159	132	130	27	1.0k
Peter Drueckes Switzerland	15	727 1.2×	290 1.2×	173 1.1×	146 1.1×	96 0.7×	24	1.2k
Indrasish Ray Chaudhuri United States	16	642 1.1×	244 1.0×	250 1.6×	93 0.7×	50 0.4×	26	1.1k
Nicola Dobbs United Kingdom	15	367 0.6×	378 1.5×	118 0.7×	95 0.7×	122 0.9×	26	899
Dario Ballinari Italy	19	608 1.0×	400 1.6×	178 1.1×	129 1.0×	72 0.6×	54	1.1k
Rhoda Arzoomanian United States	15	510 0.8×	319 1.3×	68 0.4×	148 1.1×	160 1.2×	27	947
Hisao Fukumoto Japan	17	587 1.0×	432 1.7×	119 0.7×	193 1.5×	129 1.0×	30	1.0k
Neil H. James United Kingdom	22	1.0k 1.7×	545 2.2×	70 0.4×	172 1.3×	303 2.3×	28	1.5k
M C Bibby United Kingdom	18	609 1.0×	383 1.5×	307 1.9×	62 0.5×	258 2.0×	42	1.2k
Yasuhide Hirota Japan	13	1.1k 1.8×	766 3.1×	197 1.2×	111 0.8×	119 0.9×	21	1.5k
Masashi Aonuma Japan	11	1.2k 1.9×	875 3.5×	128 0.8×	118 0.9×	122 0.9×	14	1.5k

Countries citing papers authored by Kazuhide Nakamura

Since Specialization

Citations

This map shows the geographic impact of Kazuhide Nakamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhide Nakamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhide Nakamura more than expected).

Fields of papers citing papers by Kazuhide Nakamura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuhide Nakamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhide Nakamura. The network helps show where Kazuhide Nakamura may publish in the future.

Co-authorship network of co-authors of Kazuhide Nakamura

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhide Nakamura. A scholar is included among the top collaborators of Kazuhide Nakamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhide Nakamura. Kazuhide Nakamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kiyono, Kunihiko, et al.. (2024). A PDE3A-SLFN12 Molecular Glue Exhibits Significant Antitumor Activity in TKI-Resistant Gastrointestinal Stromal Tumors. Clinical Cancer Research. 30(16). 3603–3621. 2 indexed citations

Taniguchi, Hiroya, Yuji Baba, Yoji Sagiya, et al.. (2018). Biologic Response of Colorectal Cancer Xenograft Tumors to Sequential Treatment with Panitumumab and Bevacizumab. Neoplasia. 20(7). 668–677. 7 indexed citations

Takagi, Shinji, Yoshinori Ishikawa, Akio Mizutani, et al.. (2017). LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B. Cancer Research. 77(17). 4652–4662. 66 indexed citations

Ishikawa, Yoshinori, Megumi Morimoto, Akio Mizutani, et al.. (2017). Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication. Oncogenesis. 6(9). e377–e377. 26 indexed citations

Baba, Yuji, Toshiya Tamura, Yoshihiko Satoh, et al.. (2017). Panitumumab interaction withTAS‐102 leads to combinational anticancer effects via blocking ofEGFR‐mediated tumor response to trifluridine. Molecular Oncology. 11(8). 1065–1077. 18 indexed citations

Nakamura, Kazuhide, Akio Mizutani, Hidehisa Iwata, et al.. (2013). A Novel Inhibitor of c-Met and VEGF Receptor Tyrosine Kinases with a Broad Spectrum of In Vivo Antitumor Activities. Molecular Cancer Therapeutics. 12(6). 913–924. 27 indexed citations

Mizutani, Akio, Kazuhide Nakamura, Osamu Kitahara, et al.. (2013). Anti‐angiogenic and anti‐tumor effects of TAK‐593, a potent and selective inhibitor of vascular endothelial growth factor and platelet‐derived growth factor receptor tyrosine kinase. Cancer Science. 104(4). 486–494. 16 indexed citations

Matsumoto, Shigemitsu, Naoki Miyamoto, Takaharu Hirayama, et al.. (2013). Structure-based design, synthesis, and evaluation of imidazo[1,2-b]pyridazine and imidazo[1,2-a]pyridine derivatives as novel dual c-Met and VEGFR2 kinase inhibitors. Bioorganic & Medicinal Chemistry. 21(24). 7686–7698. 48 indexed citations

Taguchi, Eri, Kazuhide Nakamura, Toru Miura, Masabumi Shibuya, & Toshiyuki Isoe. (2008). Anti‐tumor activity and tumor vessel normalization by the vascular endothelial growth factor receptor tyrosine kinase inhibitor KRN951 in a rat peritoneal disseminated tumor model. Cancer Science. 99(3). 623–630. 28 indexed citations

10.

Nakamura, Kazuhide, Eri Taguchi, Tsuyoshi Miura, et al.. (2006). KRN951, a Highly Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Has Antitumor Activities and Affects Functional Vascular Properties. Cancer Research. 66(18). 9134–9142. 164 indexed citations

11.

Asano, Takeshi, Kazuhide Nakamura, Hisaki Fujii, et al.. (2005). Altered expression of topoisomerase IIα contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation. British Journal of Cancer. 92(8). 1486–1492. 18 indexed citations

12.

Kubo, Kazuo, Toshiyuki Shimizu, Hideko Murooka, et al.. (2005). Novel Potent Orally Active Selective VEGFR-2 Tyrosine Kinase Inhibitors: Synthesis, Structure−Activity Relationships, and Antitumor Activities of N-Phenyl-N‘-{4-(4-quinolyloxy)phenyl}ureas. Journal of Medicinal Chemistry. 48(5). 1359–1366. 131 indexed citations

13.

Kubo, Kazuo, Toshiyuki Shimizu, Hideko Murooka, et al.. (2003). Synthesis and structure–activity relationship for new series of 4-Phenoxyquinoline derivatives as specific inhibitors of platelet-derived growth factor receptor tyrosine kinase. Bioorganic & Medicinal Chemistry. 11(23). 5117–5133. 19 indexed citations

14.

Kubo, Kazuo, Yutaka Fujiwara, Hideko Murooka, et al.. (2002). Synthesis and structure-activity relationship of Quinazoline-Urea derivatives as novel orally active VEGF receptor tyrosine kinase selective inhibitors. 43. 182. 1 indexed citations

15.

Nakayashiki, Toru, Kazuhide Nakamura, Hachiro Inokuchi, et al.. (2001). Abortive assembly of succinate-ubiquinone reductase (Complex II) in a ferrochelatase-deficient mutant of Escherichia coli. Molecular Genetics and Genomics. 265(3). 394–404. 21 indexed citations

16.

Yagi, Mikio, Shinichiro Kato, Yoshiko Kobayashi, et al.. (1997). Selective Inhibition of Platelet-Derived Growth Factor (PDGF) Receptor Autophosphorylation and PDGF-Mediated Cellular Events by a Quinoline Derivative. Experimental Cell Research. 234(2). 285–292. 15 indexed citations

17.

Kubo, Kazuo, Toshiyuki Shimizu, Hideko Murooka, et al.. (1997). A novel series of 4-phenoxyquinolines: potent and highly selective inhibitors of PDGF receptor autophosphorylation. Bioorganic & Medicinal Chemistry Letters. 7(23). 2935–2940. 16 indexed citations

18.

Nakamura, Kazuhide, Tadao Horiuchi, Takanori Yasukochi, et al.. (1994). Significant contribution of arginine-112 and its positive charge of Pseudomonas putida cytochrome P-450cam in the electron transport from putidaredoxin. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1207(1). 40–48. 37 indexed citations

19.

Koga, Hideo, Yasuhiro Sagara, Mitsushi Tsujimura, et al.. (1993). Essential role of the Arg¹¹² residue of cytochrome P450cam for electron transfer from reduced putidaredoxin. FEBS Letters. 331(1-2). 109–113. 58 indexed citations

20.

Suzuki, Toshiaki, et al.. (1985). Amino acid sequence of polypeptide chain IIB of extracellular hemoglobin from the polychaete Tylorrhynchus heterochaetus.. Journal of Biological Chemistry. 260(21). 11481–11487. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact